Related Experiment Videos
Functional cross-talk between p73beta and NF-kappaB mediated by p300
Sang-Mi Ryou1, Kyung-Hwa Kang, Mi-Hee Jeong
1Laboratory of Molecular Biology, Department of Biology, College of Natural Sciences, Chung-Ang University, Seoul, Republic of Korea.
Biochemical and Biophysical Research Communications
|May 16, 2006
Summary
The tumor suppressor p73beta and the survival factor NF-kappaB (Nuclear Factor kappa-light-chain-enhancer of activated B cells) mutually regulate each other. This cross-talk, mediated by p300, impacts cell apoptosis and survival.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- p73beta promotes apoptosis and growth arrest, while NF-kappaB promotes survival.
- Opposing roles suggest a regulatory mechanism controlling cell fate.
- Understanding this interplay is crucial for cancer therapy.
Purpose of the Study:
- To investigate the regulatory relationship between p73beta and NF-kappaB.
- To elucidate the role of p300 in mediating their interaction.
- To determine how this interaction affects cellular apoptosis and survival.
Main Methods:
- Assessing NF-kappaB and p73beta transactivation.
- Identifying crucial domains for regulatory interaction.
- Analyzing p300 binding and its impact on protein interactions.
Main Results:
- p73beta downregulates NF-kappaB transactivation; p65 (NF-kappaB subunit) downregulates p73beta transactivation.
- Specific domains of p73beta and p65 are essential for this reciprocal regulation.
- p73beta and p65 competitively bind to p300, inhibiting their interaction.
- p73beta-induced apoptosis and p65-induced cell survival are reciprocally repressed.
Conclusions:
- p300 acts as a central regulator in the cross-talk between p73beta and NF-kappaB.
- This competitive interaction balances their opposing biological activities.
- The findings offer insights into novel therapeutic strategies targeting cell death and survival pathways.